Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia
Public ClinicalTrials.gov record NCT04076943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open Label Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find out if roxadustat (also known as FG-4592) is safe and effective for the treatment of anemia in participants receiving chemotherapy treatment for cancer.
Study identification
- NCT ID
- NCT04076943
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 92 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 20, 2019 (Actual)
- Primary completion
- Mar 26, 2021 (Actual)
- Completion
- Apr 23, 2021 (Actual)
- Last update posted
- Jun 3, 2022
2019 – 2021
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Center | Los Alamitos | California | 90720 | — |
| Research Center | Los Angeles | California | 90024 | — |
| Research Center | Torrance | California | 90505 | — |
| Research Center | Jacksonville | Florida | 32256 | — |
| Research Center | Plantation | Florida | 33322 | — |
| Research Center | Fort Wayne | Indiana | 46804 | — |
| Research Center | Ashland | Kentucky | 41101 | — |
| Research Center | Covington | Louisiana | 70433 | — |
| Research Center | Bethesda | Maryland | 20817 | — |
| Research Center | Livingston | New Jersey | 07039 | — |
| Research Center | Port Jefferson Station | New York | 11776 | — |
| Research Center | The Bronx | New York | 10469 | — |
| Research Center | Canton | Ohio | 44718 | — |
| Research Center | Gettysburg | Pennsylvania | 17325 | — |
| Research Center | Philadelphia | Pennsylvania | 19106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04076943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2022 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04076943 live on ClinicalTrials.gov.